BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34528662)

  • 1. MYC Expression Is Associated With p53 Expression and TP53 Aberration and Predicts Poor Overall Survival in Acute Lymphoblastic Leukemia/Lymphoma.
    Gao L; Harbaugh B; Parr K; Patel P; Golem S; Zhang D; Woodroof J; Cui W
    Am J Clin Pathol; 2022 Jan; 157(1):119-129. PubMed ID: 34528662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
    Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
    Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level MYC expression associates with poor survival in patients with acute myeloid leukemia and collaborates with overexpressed p53 in leukemic transformation in patients with myelodysplastic syndrome.
    Gao L; Saeed A; Golem S; Zhang D; Woodroof J; McGuirk J; Ganguly S; Abhyankar S; Lin TL; Cui W
    Int J Lab Hematol; 2021 Feb; 43(1):99-109. PubMed ID: 32812335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of C-myc expression in T-lymphoblastic lymphoma/leukemia and its relation with prognosis].
    Zhang Y; Li J; Xi Y; Bai W; Bai W; Sun R
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):571-7. PubMed ID: 26705181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of function tp53 mutations do not accelerate the onset of myc-induced T-cell acute lymphoblastic leukaemia in the zebrafish.
    Gutierrez A; Feng H; Stevenson K; Neuberg DS; Calzada O; Zhou Y; Langenau DM; Look AT
    Br J Haematol; 2014 Jul; 166(1):84-90. PubMed ID: 24690081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?
    Hoelzer D; Gökbuget N
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S214-21. PubMed ID: 19778844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of
    Firtina S; Erbilgin Y; Hatirnaz Ng O; Karaman S; Karakas Z; Celkan TT; Gelen SA; Yildirmak Y; Ozbek U; Sayitoglu M
    Scand J Clin Lab Invest; 2023 May; 83(3):187-193. PubMed ID: 37029683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia.
    Bontoux C; Simonin M; Garnier N; Lhermitte L; Touzart A; Andrieu G; Bruneau J; Lengliné E; Plesa A; Boissel N; Baruchel A; Bertrand Y; Molina TJ; Macintyre E; Asnafi V
    Mod Pathol; 2022 Sep; 35(9):1227-1235. PubMed ID: 35562412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Children's Oncology Group.
    Smock KJ; Nelson M; Tripp SR; Sanger WG; Abromowitch M; Cairo MS; Perkins SL;
    Pediatr Blood Cancer; 2008 Oct; 51(4):489-94. PubMed ID: 18618503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Mayo Clinic Clinical and Pathologic Study.
    Khurana S; Heckman MG; Craig FE; Cochuyt JJ; Greipp P; Rahman ZA; Sproat LZ; Litzow M; Foran JM; Jiang LJ
    Arch Pathol Lab Med; 2024 Apr; 148(4):471-475. PubMed ID: 37522711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.
    Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS
    Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Many Tests Does It Take to Diagnose a Triple-Hit B-Lymphoblastic Lymphoma? (Hint, It's A Lot).
    Das M; Tsuchiya KD; Bohling SD; Davis B; Hwang S; Gardner RA; Chisholm KM
    Pediatr Dev Pathol; 2024; 27(2):193-197. PubMed ID: 38032739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
    J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement: Report of 3 Cases in Adult Patients.
    Li Y; Gupta G; Molofsky A; Xie Y; Shihabi N; McCormick J; Jaffe ES
    Am J Surg Pathol; 2018 Feb; 42(2):269-276. PubMed ID: 29112016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma.
    Lee WJ; Moon HR; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
    J Am Acad Dermatol; 2014 Feb; 70(2):318-25. PubMed ID: 24314877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and clinical relevance of DNA microsatellite alterations of the CDKN2A/B, ATM and p53 gene loci: a comparison between pediatric precursor T-cell lymphoblastic lymphoma and T-cell lymphoblastic leukemia.
    Krieger D; Moericke A; Oschlies I; Zimmermann M; Schrappe M; Reiter A; Burkhardt B
    Haematologica; 2010 Jan; 95(1):158-62. PubMed ID: 19586936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of miR-16 in patients with T lymphoblastic lymphoma/acute lymphoblastic leukemia].
    Tong LG; Wu WZ; Zhang YP; Zhou ZG; Chen YF; Huang WJ; Xu H; Su QQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):99-103. PubMed ID: 24598659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic challenges in T-lymphoblastic lymphoma, early T-cell precursor acute lymphoblastic leukemia or mixed phenotype acute leukemia: A case report.
    Wang P; Peng X; Deng X; Gao L; Zhang X; Feng Y
    Medicine (Baltimore); 2018 Oct; 97(41):e12743. PubMed ID: 30313079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow Cytometric Evaluation of Double/Triple Hit Lymphoma.
    Roth CG; Gillespie-Twardy A; Marks S; Agha M; Raptis A; Hou JZ; Farah R; Lin Y; Qian Y; Pantanowitz L; Boyiadzis M
    Oncol Res; 2016; 23(3):137-46. PubMed ID: 26931436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.